Study to test the safety, efficacy and PK properties of CSL627

• Research type

  Research Study

• Full title

  A Phase I/III Open-label, Multicenter, Crossover Safety, Efficacy and Pharmacokinetic Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Human Antihaemophilic Factor VIII (rFVIII; INN: octocog alfa) in Subjects with Hemophilia A, and a Repeat PK, Safety and Efficacy Study

• IRAS ID

  127759

• Contact name

  Pratima Chowdary

• Contact email

  p.chowdary@nhs.net

• Sponsor organisation

  CSL Behring GmbH

• Eudract number

  2011-002393-23

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  13/LO/0599

• Date of REC Opinion

  13 Aug 2013

• REC opinion

  Further Information Favourable Opinion